Brief: Lineage Cell Therapeutics Q3 Net Income USD -29.752 Million
06/11/2025 21:01
Nov 06 (Reuters) - Lineage Cell Therapeutics Q3 operating expenses USD 7.467 million. Q3 income from operations USD -3.786 million
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million